Related references
Note: Only part of the references are listed.Duration of second or greater complete clinical remission in ovarian cancer: Exploring potential endpoints for clinical trials
Michelle L. Harrison et al.
GYNECOLOGIC ONCOLOGY (2007)
Secondary cytoreductive surgery for isolated nodal recurrence in patients with epithelial ovarian cancer
Antonio Santillan et al.
GYNECOLOGIC ONCOLOGY (2007)
Secondary cytoreductive surgery in patients with platinum-sensitive recurrent ovarian cancer
Pierluigi Benedetti Panici et al.
ANNALS OF SURGICAL ONCOLOGY (2007)
Cytoreductive surgery for patients with recurrent epithelial ovarian carcinoma
Stephen J. Tebes et al.
GYNECOLOGIC ONCOLOGY (2007)
Role of salvage cytoreductive surgery in the treatment of patients with recurrent ovarian cancer after platinum-based chemotherapy
Aya Matsumoto et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH (2006)
Surgery in recurrent ovarian cancer:: The Arbeitsgemeinschaft Gynaekologische Onkologie (AGO) DESKTOP OVAR Trial
Philipp Harter et al.
ANNALS OF SURGICAL ONCOLOGY (2006)
The role of secondary cytoreduction in the treatment of ovarian cancer: Hacettepe University experience
A Ayhan et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2006)
Long-term survival advantage for women treated with pegylated liposomal doxorubicin compared with topotecan in a phase 3 randomized study of recurrent and refractory epithelial ovarian cancer
AN Gordon et al.
GYNECOLOGIC ONCOLOGY (2004)
Secondary cytoreductive surgery for localized intra-abdominal recurrences in epithelial ovarian cancer
A Munkarah et al.
GYNECOLOGIC ONCOLOGY (2001)
Complete salvage surgical cytoreduction improves further survival of patients with late recurrent ovarian cancer
A Gadducci et al.
GYNECOLOGIC ONCOLOGY (2000)
Share Paper
